Dallas Salazar
IPOs, contrarian, long/short equity, long-term horizon

Care.com's Divergence Between Improving Fundamentals And Declining Stock Performance Should Soon End

This article will discuss Care.com (NYSE:CRCM), the significant divergence between the company's falling stock price and the company's improving fundamental picture, and how that divergence should soon begin closing. If you are unfamiliar with the business of CRCM, I would recommend reading any number of the articles listed at Seeking Alpha under the ticker. I also would recommend doing as much due diligence as possible before placing a buy or short order as the stock has traded in a wide range of $9.57-$29.25 since its IPO and has a high beta.

The Tale of Two Cities

It's been 3 months since I wrote about what I believed was a great business developing at CRCM. At the time, the...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details